Table 1.
Spectrum of ADEs in patients with kidney dysfunction
Study | ADE category | Example |
---|---|---|
Miller et al. (2009)46 Zand et al. (2010)47 |
Inappropriate medication dosing for level of kidney function |
Gabapentin 300 mg three times daily in a patient with an eGFR of 20 ml/min/1.73 m2, leading to central nervous system depression |
Williams et al. (2004)48 Sica et al. (2004)49 |
Drug–drug interactions in patients with advanced CKD |
Increased risk of bradycardia with atenolol and diltiazem (drugs cleared via the kidney) in a patient with end-stage renal disease |
Chen (2009)50 | Inappropriate prescribing | Use of morphine in a patient with stage 5 CKD, leading to accumulation of active metabolites |
Bernstein et al. (1990)51 | Inadequate monitoring | High levels of aminoglycoside in a patient receiving antibiotics for a prolonged period of time |
Connolly et al. (2009)52 | Failure to identify CKD | Reliance on serum creatinine concentration alone to assess renal function in an elderly patient |
Perazella et al. (2009)53 | Inappropriate diagnostic test | Use of gadolinium for MRI contrast in a patient with stage 5 CKD |
Abbreviations: ADE, adverse drug event; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.